Metraipolis › archive › dc_f2cbce96f4b0
Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease — Europe PMC PMID:41656560
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41656560
- DOI
- 10.1177/1877718x261420002
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T01:04:33.809Z
- SHA-256 of the archived text
ca578cde5a4a417ab2e69787bce545c25a5c3c2209ea611d0b8551fcf9fc4a10- Stable URL of this page
https://metraipolis.com/documento/dc_f2cbce96f4b0
How to cite
Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease — Europe PMC PMID:41656560 — Europe PMC (en), https://europepmc.org/article/MED/41656560 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2cbce96f4b0 (Metraipolis archive dc_f2cbce96f4b0, sha256 ca578cde5a4a417ab2e69787bce545c25a5c3c2209ea611d0b8551fcf9fc4a10)
BibTeX
@misc{dcf2cbce96f4b0,
title = {Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease — Europe PMC PMID:41656560},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41656560},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2cbce96f4b0; sha256 ca578cde5a4a417ab2e69787bce545c25a5c3c2209ea611d0b8551fcf9fc4a10},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41656560. Agents can read the archived copy with the MCP tool read_document.